MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals : a randomised placebo-controlled trial.

978 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

COMBINED EFFECTS OF ORGANIZATIONAL AND PROFESSIONAL IDENTIFICATION ON THE RECIPROCITY DYNAMIC FOR PROFESSIONAL EMPLOYEES (2009, background): “The drugs prevent one cardiac event for every 19 patients treated with statins over a five-year period (Heart Protection Study Collaborative Group, 2002) or for every 18 patients treated with ACE inhibitors over five years (Acute Infarction Ramipril Efficacy Study Investigators, 1993).”